Jasper Therapeutics Inc [JSPR] stock prices are up 10.46% to $16.58 at the moment. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The JSPR shares have gain 4.61% over the last week, with a monthly amount drifted -27.12%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Jasper Therapeutics Inc [NASDAQ: JSPR] stock has seen the most recent analyst activity on September 09, 2024, when JMP Securities initiated its Mkt Outperform rating and assigned the stock a price target of $70. Previously, BTIG Research started tracking the stock with Buy rating on July 08, 2024, and set its price target to $90. On June 27, 2024, Stifel initiated with a Buy rating and assigned a price target of $86 on the stock. H.C. Wainwright started tracking the stock assigning a Buy rating and suggested a price target of $65 on May 06, 2024. Evercore ISI initiated its recommendation with a Outperform and recommended $65 as its price target on April 03, 2024. RBC Capital Mkts started tracking with a Outperform rating for this stock on March 28, 2024, and assigned it a price target of $70. In a note dated March 18, 2024, TD Cowen initiated an Outperform rating.
The stock price of Jasper Therapeutics Inc [JSPR] has been fluctuating between $4.00 and $31.01 over the past year. Currently, Wall Street analysts expect the stock to reach $34.75 within the next 12 months. Jasper Therapeutics Inc [NASDAQ: JSPR] shares were valued at $16.58 at the most recent close of the market. An investor can expect a potential return of 109.59% based on the average JSPR price forecast.
Analyzing the JSPR fundamentals
Gross Profit Margin for this corporation currently stands at 0.44% with Operating Profit Margin at -33.21%, Pretax Profit Margin comes in at -30.43%, and Net Profit Margin reading is -30.43%. To continue investigating profitability, this company’s Return on Assets is posted at -0.55, Equity is -0.65 and Total Capital is -0.66. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.02.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 14.56 points at the first support level, and at 12.53 for the second support level. However, for the 1st resistance point, the stock is sitting at 19.11, and for the 2nd resistance point, it is at 21.63.
Ratios To Look Out For
It’s worth pointing out that Jasper Therapeutics Inc [NASDAQ:JSPR]’s Current Ratio is 10.79. Also, the Quick Ratio is 10.79, while the Cash Ratio stands at 10.61.
Transactions by insiders
Recent insider trading involved Mahal Jeetinder Singh, Chief Operating Officer, that happened on Sep 12 ’24 when 900.0 shares were sold. Executive Officer, Jeetinder Singh Mahal completed a deal on Sep 12 ’24 to buy 900.0 shares. Meanwhile, Chief Operating Officer Mahal Jeetinder Singh sold 900.0 shares on Jun 12 ’24.
